RHÖN-KLINIKUM AG Maintains Steady Performance in Q1 2025

RHÖN-KLINIKUM AG, a significant player in the German healthcare sector, reported stable operations in the first quarter of 2025. From January to March, the group treated 240,137 patients, slightly up from the previous year's 234,151. The company saw an 8.3% revenue rise to EUR 414.7 million, compared to EUR 382.8 million in Q1 2024. However, EBITDA decreased to EUR 22.6 million from EUR 25.2 million, primarily due to the cessation of government funds for energy expenses and lower interest rates.

The company's strategic positioning within the Asklepios Group helps navigate current challenges, allowing continued investment in healthcare quality. Notably, RHÖN-KLINIKUM operates five sites offering a range of medical services. For 2025, they forecast EUR 1.7 billion in revenues, while acknowledging uncertainties from global crises and regulatory changes impacting medical remuneration.